Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
PASADENA, Calif., March 5 /PRNewswire-FirstCall/ -- China Healthcare Acquisition Corp. (the "Company") (NYSE Alternext US: CHM, CHM-U, CHM-WS) announced that at its annual meeting held today...
PASADENA, Calif., Feb. 20 /PRNewswire-FirstCall/ -- China Healthcare Acquisition Corp. (the "Company") (NYSE Alternext US: CHM, CHM-U, CHMW) announced today that its Board of Directors has set...
Worldwide Electronic Lab Notebooks Industry Symposium Co-Sponsored by Synthematix, Symyx IntelliChem & Waters, Apr 4-5 in Boston BOSTON, March 24 /PRNewswire/ -- The much anticipated Electronic...
RNS Number:5606T Chemetall PLC 22 December 2003 On behalf of: Chemetall PLC Date: 22 December 2003 Re: Change of Directorate Mr Jurgen Faesel will resign as non-executive Director of...
RNS Number:2215S Chemetall PLC 18 November 2003 Chairman's statement The past twelve months have proved to be challenging for the group due to the continued weak trading...
RNS Number:5725Q Chemetall PLC 06 October 2003 On behalf of: Chemetall PLC Date: 6 October 2003 The Company's ultimate holding company, mg technologies ag ("mg") has announced its...
RNS Number:2205L Chemetall PLC 19 May 2003 Unaudited Interim Results for the six months ended 31 March 2003 Chairman's statement In the 2002 financial statements we reported our...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.005 | 0.005 | 0.005 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.005 | 0.005 | 0.005 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.005 | 0.005 | 0.005 | 0 | 0 | CS |
| 26 | -0.045 | -90 | 0.05 | 0.05 | 0.005 | 1723 | 0.05 | CS |
| 52 | -0.045 | -90 | 0.05 | 0.05 | 0.005 | 2566 | 0.05 | CS |
| 156 | -0.395 | -98.75 | 0.4 | 0.65 | 0.005 | 31642 | 0.23232943 | CS |
| 260 | -1.245 | -99.6 | 1.25 | 3 | 0.005 | 115777 | 0.849427 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
